Probiotic strains for use in improving transepithelial resistance
US9402872B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 2011 |
| Grant date | Aug 2, 2016 |
| Priority date | — |
| Expiry date | May 30, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2400/533
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of lactic acid bacteria, for use in improving transepithelial resistance and more particularly in treating and/or preventing constipation and/or irritable bowel disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.